Iodide

Iodide

SCHEMBL6190800

CC(=N)c1c(F)cccc1F.I

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.35
CES2 O00748 3/20 0.48
CES1 P23141 3/20 0.48
TDP1 Q9NUW8 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 1/20 0.36
ERN1 O75460 1/20 0.35
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
HTT P42858 2/20 0.33
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
NOD2 Q9HC29 1/20 0.33
BCHE P06276 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22790321 0.84 ACHE (0.46) CES2CES1TDP1KMT2ALMNA
SCHEMBL1990301 0.76 CES2 (0.55) CES2CES1TDP1KMT2ALMNA
SCHEMBL20822051 0.73 CES2 (0.34) CES2CES1TDP1KMT2AMEN1
SCHEMBL167447 0.72 CES2 (0.64) CES2CES1TDP1KMT2ALMNA
SCHEMBL14333527 0.72 CES2 (0.50) CES2CES1KMT2ALMNAMEN1
SCHEMBL7924194 0.72 CES2 (0.50) CES2CES1TDP1KMT2ALMNA
SCHEMBL12332545 0.72 CES2 (0.34) CES2CES1KMT2AERN1GAA
SCHEMBL10040477 0.71 CES2 (0.56) CES2CES1KMT2AERN1ACHE
SCHEMBL8597809 0.71 CES2 (0.44) CES2CES1TDP1KMT2AMEN1
SCHEMBL16223170 0.71 CES2 (0.44) CES2CES1TDP1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1124827-B1 3-(SUBSTITUTED PHENYL)-5-(SUBSTITUTED HETEROCYCLYL)-1,2,4-TRIAZOLE COMPOUNDS DOW AGROSCIENCES LLC (US) 2005-11-30 EP disclosed
EP-1123281-B1 3-(SUBSTITUTED PHENYL)-5-(SUBSTITUTED CYCLOPROPYL)-1,2,4-TRIAZOLE COMPOUNDS DOW AGROSCIENCES LLC (US) 2003-10-22 EP disclosed
US-6417187-B2 PALLADIUM CATALYZED ARYLATION, ALKYLATION, DEIODINATION OR DEBROMINATION DOW AGROSCIENCES LLC 2002-07-09 US disclosed
US-6413997-B1 INSECTICIDES, MITICIDES DOW AGROSCIENCES LLC 2002-07-02 US disclosed
US-20020019370-A1 Palladium catalyzed arylation, alkylation, deiodination or debromination DOW AGROSCIENCES LLC 2002-02-14 US disclosed
EP-0922043-B1 PESTICIDAL 3-(SUBSTITUTED PHENYL)-5-(THIENYL OR FURYL)-1,2,4-TRIAZOLES DOW AGROSCIENCES LLC (US) 2002-01-30 EP disclosed
EP-1124827-A1 3-(SUBSTITUTED PHENYL)-5-(SUBSTITUTED HETEROCYCLYL)-1,2,4-TRIAZOLE COMPOUNDS Dow AgroSciences LLC (US) 2001-08-22 EP disclosed
EP-1123281-A1 3-(SUBSTITUTED PHENYL)-5-(SUBSTITUTED CYCLOPROPYL)-1,2,4-TRIAZOLE COMPOUNDS Dow AgroSciences LLC (US) 2001-08-16 EP disclosed
US-6262305-B1 Process and intermediates for preparing 3-(substituted phenyl)-5-(thienyl or furyl)-1,2,4-triazole compounds DOW AGROSCIENCES LLC 2001-07-17 US disclosed
US-6262099-B1 USEFUL AS INSECTICIDES AND ACARICIDES. DOW AGROSCIENCES LLC 2001-07-17 US disclosed
EP-1113004-A2 Intermediates for producing 3-(substituted phenyl)-5-(thienyl or furyl)-1,2,4-triazole compounds Dow Agrosciences LLC (US) 2001-07-04 EP disclosed
WO-2000024739-A1 3-(SUBSTITUTED PHENYL)-5-(SUBSTITUTED HETEROCYCLYL)-1,2,4-TRIAZOLE COMPOUNDS DOW AGROSCIENCES LLC (US) 2000-05-04 WO disclosed
WO-2000024720-A1 3-(SUBSTITUTED PHENYL)-5-(SUBSTITUTED CYCLOPROPYL)-1,2,4-TRIAZOLE COMPOUNDS DOW AGROSCIENCES LLC (US) 2000-05-04 WO disclosed
US-6015826-A INSECTICIDES, APHIDICIDES, AND MITICIDES DOW AGROSCIENCES LLC 2000-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019370-A1 Palladium catalyzed arylation, alkylation, deiodination or debromination DDT, TYR, DDC ACHE 60/4885CES2 393/4885CES1 504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.